Representative Publications From a Total of 49:
Malenka DJ, McGrath PD, Wennberg DE, Ryan TJ, Jr., Kellett MA, Shubrooks SJ, Jr., Bradley WA, Hettlemen BD, Robb JF, Hearne MJ, Silver TM, Watkins MW, O’Meara JR, VerLee PN, O’Rourke DJ. The relationship between operator volume and outcomes following percutaneous coronary interventions in high volume hospitals in 1994 –1996: The northern New England Experience. Northern New England Cardiovascular Disease Study Group [see comments]. J Am Coll Cardiol 1999; 34:1471–1480.
Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, Tryzelaar JF, Clough R, Hearne MJ, Hernandez F, Jr., Watkins MW, O’Connor GT. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001; 37:1008-1015.
Kabbani SS, Watkins MW, Ashikaga T, Terrien E, Holoch P, Sobel BE, Schneider DJ. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001; 104:181-186
Watkins MW, Kellett MA, Shubrooks SJ, Jr., Hettleman BD, Hearne MJ, Ver Lee PN, Schmitz JM, Ryan TJ, McGrath PD, Piper WE, Dauerman HL, Robb J, Malenka DJ. Percutaneous coronary interventions in bypass grafts in Northern New England 1990 – 2000: Improved acute outcomes in the era of stents. Presented at AHA, Chicago, IL, 11/2002.
Grines C, Watkins MW, Helmer G, Penny W, Brinker J, Marmur J, West A, Rade JJ, Marrott P, Hammond HK, Engler RL. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291-1297.
Grines C, Watkins MW, Mahmarian JJ, Iskandrian AE, Marrott P, Pratt C, Kleiman N. A randomized double blind placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina (AGENT 2). J Am Coll Cardiol 2003; 42:1339-1347.
Watkins MW, Rubanyi GM. Gene therapy for coronary artery disease: Preclinical and initial clinical results with intracoronary Ad5-FGF4 in Human gene therapy: Current opportunities and future trends edited by Rubanyi GM and Yla-Herttuala S. Springer-Verlag, Heidelberg, Germany, 2003, pp 173-188.
Teirstein PS, Kao J, Watkins M, Tannenbaum MA, Laufer N, Chang M, Mehran R. Dangas, G. Russell ME, Ellis SG, Stone GW. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). Am J Cardiol 2005; 96:500-505.
Watkins MW, editor. Review in Depth: Cardiac computed tomography. Coron Artery Dis 2006; 17:99-130.
Watkins MW, Hesse B, Green CE, Greenberg NL, Manning M, Chaudhry E, Dauerman HL, Garcia MJ. Detection of coronary artery stenosis using 40-channel computed tomography with multi-segment reconstruction. Am J Cardiol 2007; 99:175-181.